Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Felipe Jain, M.D.

Concepts (164)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Felipe Jain's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Felipe Jain has written about over time.
Arachnoid Cysts, 1 publications between 2008 and 2008, average publication date March 2008. Meningomyelocele, 1 publications between 2008 and 2008, average publication date March 2008. Arthroplasty, Replacement, 1 publications between 2011 and 2011, average publication date August 2011. Mind-Body Therapies, 1 publications between 2014 and 2014, average publication date April 2014. Citalopram, 4 publications between 2013 and 2016, average publication date October 2014. Depressive Disorder, Major, 12 publications between 2008 and 2022, average publication date August 2015. Antidepressive Agents, 4 publications between 2013 and 2019, average publication date August 2016. Meditation, 5 publications between 2012 and 2022, average publication date December 2016. Sleep Initiation and Maintenance Disorders, 2 publications between 2014 and 2022, average publication date February 2018. Dementia, 4 publications between 2014 and 2022, average publication date December 2018. Caregivers, 3 publications between 2014 and 2022, average publication date June 2019. Hydrocortisone, 1 publications between 2019 and 2019, average publication date July 2019. Memory, 1 publications between 2019 and 2019, average publication date July 2019.

To see the data from this visualization as text, click here.
Jain's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (164)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.